TMED10P1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.706000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.272200E-01
Normal-vs-Stage2
8.961800E-01
Normal-vs-Stage3
4.927700E-02
Normal-vs-Stage4
3.448200E-01
Stage1-vs-Stage2
6.377400E-01
Stage1-vs-Stage3
1.123210E-01
Stage1-vs-Stage4
3.842600E-01
Stage2-vs-Stage3
3.779100E-03
Stage2-vs-Stage4
3.251200E-01
Stage3-vs-Stage4
1.353560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.641200E-01
Normal-vs-AfricanAmerican
9.379200E-01
Normal-vs-Asian
6.263000E-01
Caucasian-vs-AfricanAmerican
7.303000E-01
Caucasian-vs-Asian
2.402000E-01
AfricanAmerican-vs-Asian
6.231800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.653800E-01
Normal-vs-Female
8.861400E-01
Male-vs-Female
9.254400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.130800E-01
Normal-vs-Age(41-60Yrs)
6.361600E-01
Normal-vs-Age(61-80Yrs)
9.665600E-01
Normal-vs-Age(81-100Yrs)
7.909400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.830600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.081600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.481200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.261700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.533400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.549000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.066800E-01
Normal-vs-Daily Drinker
4.573400E-01
Normal-vs-Weekly Drinker
7.796000E-01
Normal-vs-Occasional Drinker
5.404200E-01
Normal-vs-Social Drinker
5.584000E-01
Non Drinker-vs-Daily Drinker
3.862600E-01
Non Drinker-vs-Weekly Drinker
8.767400E-01
Non Drinker-vs-Occasional Drinker
6.196100E-02
Non Drinker-vs-Social Drinker
7.842400E-02
Daily Drinker-vs-Weekly Drinker
5.987000E-01
Daily Drinker-vs-Occasional Drinker
2.565500E-02
Daily Drinker-vs-Social Drinker
4.604400E-02
Weekly Drinker-vs-Occasional Drinker
1.314970E-01
Weekly Drinker-vs-Social Drinker
1.540210E-01
Occasional Drinker-vs-Social Drinker
9.962400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.795390E-01
Normal-vs-Grade 2
7.150200E-02
Normal-vs-Grade 3
7.230000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.679800E-01
Grade 1-vs-Grade 3
5.317200E-01
Grade 1-vs-Grade 4
1.795390E-01
Grade 2-vs-Grade 3
6.587600E-02
Grade 2-vs-Grade 4
7.150200E-02
Grade 3-vs-Grade 4
7.230000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.474000E-01
Normal-vs-NonDiabetic
9.622400E-01
Diabetic-vs-NonDiabetic
7.376800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.901410E-01
Normal-vs-NoPancreatitis
8.997800E-01
Pancreatitis-vs-NoPancreatitis
6.298500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.653200E-01
Normal-vs-N1
8.643600E-01
N0-vs-N1
8.334200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.969600E-01
Normal-vs-TP53-NonMutant
7.274800E-01
TP53-Mutant-vs-TP53-NonMutant
2.869000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
